304 related articles for article (PubMed ID: 9821235)
1. [Long-term atrovent treatment of chronic obstructive bronchitis].
Simanenkov VI; Il'iashevich IG; Liparteliani BG; Ledovaia AV
Ter Arkh; 1998; 70(9):77-9. PubMed ID: 9821235
[TBL] [Abstract][Full Text] [Related]
2. [Long-term atrovent treatment of chronic obstructive bronchitis].
Khristoliubova EI; Volkova LI; Shcherbakova IV
Klin Med (Mosk); 1999; 77(12):51-2. PubMed ID: 10684219
[No Abstract] [Full Text] [Related]
3. [Experience in long-term use of berodual in the treatment of patients with chronic obstructive bronchitis].
Shmelev EI; Khmel'kova NG; Nonikov DV; Melent'eva EM; Abubikirov AF; Makarova VL; Mazaeva LA; Ushakova TI
Ter Arkh; 1999; 71(3):22-4. PubMed ID: 10234758
[TBL] [Abstract][Full Text] [Related]
4. [Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation].
Shmelev EI; Khmel'kova NG; Abubikirov AF
Ter Arkh; 2000; 72(3):26-8. PubMed ID: 10776649
[TBL] [Abstract][Full Text] [Related]
5. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
Ashutosh K; Lang H
Ann Allergy; 1984 Nov; 53(5):401-6. PubMed ID: 6238558
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
7. [Basic medication of chronic obstructive lung disease with berodual].
Melent'eva EM
Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
[No Abstract] [Full Text] [Related]
8. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.
Petersen BN; Weeke E
Scand J Respir Dis Suppl; 1979; 103():178-82. PubMed ID: 155295
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease].
Malinowski R; Frank-Piskorska A; Wasek Z; Koczorowski T
Pneumonol Pol; 1986 Mar; 54(3):91-5. PubMed ID: 2942842
[No Abstract] [Full Text] [Related]
10. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
Iakushin SS; Smirnova EA
Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
[No Abstract] [Full Text] [Related]
11. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
Stauder J; Flasch CI
Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
[No Abstract] [Full Text] [Related]
12. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
[TBL] [Abstract][Full Text] [Related]
13. [Role of bronchospasm in development of bronchial obstruction in chronic bronchitis].
Nefedov VB; Shergina EA
Ter Arkh; 2000; 72(11):57-9. PubMed ID: 11229314
[TBL] [Abstract][Full Text] [Related]
14. [Inhalation of high-doses of ipratropium bromide (Atrovent) does not cause any changes in systemic or pulmonary hemodynamics].
Král B; Gregor J; Parízek P; Pudil R; Jílková V
Cas Lek Cesk; 2000 Feb; 139(2):49-50. PubMed ID: 10802931
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
[TBL] [Abstract][Full Text] [Related]
16. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
[TBL] [Abstract][Full Text] [Related]
18. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
19. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
Musil J
Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
[TBL] [Abstract][Full Text] [Related]
20. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
Verstraeten JM
Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
